NASDAQ:SGRY - Surgery Partners Stock Price, Forecast & News

Surgery Partners' stock was trading at $8.86 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SGRY shares have decreased by 25.3% and is now trading at $6.62. View which stocks have been mosted impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Surgery Partners.

Surgery Partners is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Surgery Partners.

Surgery Partners Inc (NASDAQ:SGRY) released its earnings results on Thursday, March, 5th. The company reported $0.10 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.12 by $0.02. The company earned $517.20 million during the quarter, compared to analysts' expectations of $504.08 million. Surgery Partners had a negative net margin of 4.03% and a negative return on equity of 2.42%. View Surgery Partners' earnings history.

5 Wall Street analysts have issued 1 year price targets for Surgery Partners' stock. Their forecasts range from $12.00 to $20.00. On average, they expect Surgery Partners' stock price to reach $16.80 in the next twelve months. This suggests a possible upside of 153.8% from the stock's current price. View analysts' price targets for Surgery Partners.

Media headlines about SGRY stock have been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Surgery Partners earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutSurgery Partners.

Surgery Partners saw a decrease in short interest during the month of February. As of February 28th, there was short interest totaling 2,720,000 shares, a decrease of 11.1% from the February 13th total of 3,060,000 shares. Based on an average trading volume of 449,000 shares, the days-to-cover ratio is presently 6.1 days. Currently, 13.6% of the company's stock are sold short. View Surgery Partners' Current Options Chain.

Some companies that are related to Surgery Partners include HCA Healthcare (HCA), Universal Health Services (UHS), Tenet Healthcare (THC), Community Health Systems (CYH) and Quorum Health (QHC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Verizon Communications (VZ), Amarin (AMRN), NVIDIA (NVDA), Visa (V), Advanced Micro Devices (AMD), Editas Medicine (EDIT), Mazor Robotics (MZOR), Xilinx (XLNX), Bank of America (BAC) and Canopy Growth (CGC).

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Surgery Partners' stock is owned by a variety of retail and institutional investors. Top institutional investors include Royce & Associates LP (2.83%), Goldman Sachs Group Inc. (1.46%), Pictet Asset Management Ltd. (1.29%), State Street Corp (1.00%), Kennedy Capital Management Inc. (0.70%) and Geode Capital Management LLC (0.65%). Company insiders that own Surgery Partners stock include Adam T Feinstein, Brandan Lingle, Jason Eric Evans and Teresa Deluca. View institutional ownership trends for Surgery Partners.

SGRY stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Schonfeld Strategic Advisors LLC, Strs Ohio, Nuveen Asset Management LLC, Royce & Associates LP, Dimension Capital Management LLC, Victory Capital Management Inc., and Victory Capital Management Inc.. View insider buying and selling activity for Surgery Partners.

SGRY stock was purchased by a variety of institutional investors in the last quarter, including Oxford Asset Management LLP, Marshall Wace LLP, Geode Capital Management LLC, State Street Corp, Public Sector Pension Investment Board, Trexquant Investment LP, California Public Employees Retirement System, and Los Angeles Capital Management & Equity Research Inc.. Company insiders that have bought Surgery Partners stock in the last two years include Jason Eric Evans, and Teresa Deluca. View insider buying and selling activity for Surgery Partners.

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SGRY stock can currently be purchased for approximately $6.62.

Surgery Partners has a market capitalization of $326.30 million and generates $1.83 billion in revenue each year. The company earns $-74,800,000.00 in net income (profit) each year or ($1.10) on an earnings per share basis. Surgery Partners employs 9,600 workers across the globe. View additional information about Surgery Partners.

The official website for Surgery Partners is http://www.surgerypartners.com/.

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]